CLS is committed to providing the media with timely and accurate information related to California’s life sciences ecosystem. CLS welcomes all media inquiries from news organizations and reporters. Members of the media interested in speaking with CLS opinion leaders on issues of public policy, life sciences innovation, or issues related to the life sciences ecosystem in California, please contact our communication department.

Media Contact: [email protected]

High School science prodigy wins California Life Sciences 2023 Bay Area BioGENEius Challenge

Apr 28, 2023

SOUTH SAN FRANCISCO, Calif. – California Life Sciences (CLS) on Friday named Harker School 11th grader, Ella Lan, the first-place winner of the CLS 2023 Bay Area BioGENEius Challenge—the premier..

Read More

LISTEN: CLS CEO Mike Guerra on the Vital Health Podcast

Mar 16, 2023

Tune into this lively discussion exploring the impact of the Inflation Reduction Act on California life sciences companies, how CLS is working with lawmakers, and what we’re hearing and seeing..

Read More

California Life Sciences releases statement on Silicon Valley Bank (SVB)

Mar 13, 2023

March 13, 2023 SOUTH SAN FRANCISCO, LOS ANGELES, SAN DIEGO, WASHINGTON D.C. — The failure of Silicon Valley Bank (SVB) Friday has been a major shock to life sciences companies..

Read More

San Diego’s Top 50 Black Leaders Awards

Feb 27, 2023

One of San Diego’s Top 50 Black Leaders Aims to Change the Life Sciences Industry   San Diego, Calif. – The San Diego Business Journal has recognized California Life Sciences’..

Read More

Life Sciences Startup Accelerator Program to Help Record Number of Companies

Feb 22, 2023

February 22, 2023 SAN FRANCISCO, SAN DIEGO, LOS ANGELES, SACRAMENTO, Calif. – A dozen life sciences startups have been selected to receive 12 weeks of business mentoring from expert advisors..

Read More

CLS applauds Congress for passage of the CAROL Act, supporting research for valvular heart disease

Dec 5, 2022

December 5, 2022 California Life Sciences (CLS) commends the Senate and the House of Representatives on the passage of the Cardiovascular Advances in Research and Opportunities Legacy (CAROL) Act, which..

Read More